Highlights Quanterix Corporation

Equities

QTRX

US74766Q1013

Real-time Estimate Cboe BZX Other stock markets 03:56:08 2024-04-29 pm EDT			5-day change	1st Jan Change
15.56 ^USD	+0.03%		-3.40%	-42.41%

05:14pm	Canaccord Genuity Adjusts Price Target on Quanterix to $25 From $32, Maintains Buy Rating	MT
Apr. 12	Quanterix Corporation Announces Laurie Olson, Director Will Not Stand for Re-Election	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Quanterix Corporation Receives Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer?s Disease	Mar. 04	CI
Quanterix Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Quanterix Corporation Provides Earnings Guidance for the Year 2024	Feb. 29	CI
Quanterix Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Earnings Flash (QTRX) QUANTERIX CORPORATION Reports Q4 Revenue $31.5M, vs. Street Est of $29.8M	Feb. 29	MT
Quanterix Corporation Reaffirms Earnings Guidance for the Year 2023	Feb. 26	CI
Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer?S Disease	Feb. 26	CI
Earnings Flash (QTRX) QUANTERIX CORPORATION Reports Q3 Revenue $31.3M, vs. Street Est of $27.6M	Nov. 06	MT
Quanterix Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06	CI
Earnings Flash (QTRX) QUANTERIX CORPORATION Reports Q3 Revenue $31.3M, vs. Street Est of $27.6M	Nov. 06	MT
Quanterix Corporation Revises Earnings Guidance for the 2023	Nov. 06	CI
Quanterix Launches High Accuracy P-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimer's Disease	23-10-24	CI
Quanterix Signs License Deal for Johnson & Johnson's p-Tau 217 Antibodies, Assay Designs	23-10-24	MT
Quanterix Corporation Appoints William P. Donnelly to its Board of Directors	23-08-21	CI
Earnings Flash (QTRX) QUANTERIX CORPORATION Reports Q2 Revenue $31M, vs. Street Est of $25.9M	23-08-07	MT
Quanterix Corporation Provides Earnings Guidance for the Full-Year 2023	23-08-07	CI
Quanterix Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
Quanterix Corporation Launches LucentAD Biomarker Blood Test to Aid Physician Diagnosis of Alzheimer's Disease in Patients	23-07-06	CI
Quanterix Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
Quanterix Corporation Provides Earnings Guidance for the Full Year 2023	23-05-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Quanterix Corporation

Equities

QTRX

US74766Q1013

Highlights

Filters